All In Biotech

Drug Trial Radar · NCT02299739

Liver Enzyme Abnormalities and Risk Factors in Taking Herbal Medicine

Liver Enzyme Abnormalities and Its Risk Factors in Taking Traditional Herbal Medicine in Korea

Last checked: Nov 20, 2026Latest source record: Nov 7, 2018 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

6,894

Actual

Start

Dec 2005

Primary completion

Dec 2013

Study completion Dec 2013

Sponsor

Lead sponsor
Jaseng Hospital of Korean MedicineAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Nov 24, 2014

More drug trials from this sponsor

Design

Study type
Observational
Who can join
All sexes
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Herb-induced liver injury is an important issue in musculoskeletal diseases where herbal medicine is most frequently used. The low prevalence of drug-induced liver injury (DILI) gives rise to the need for large-scale patient studies. We assessed the prevalence of liver injury of 6,894 musculoskeletal disease inpatients taking herbal medicine.

Conditions

  • Drug-Induced Liver Injury
  • Musculoskeletal Diseases

Interventions

  • Herbal medicineDrug

    Herbal medicine was taken 3 times daily in dried powder (2g) and water-base decoction form (120ml) (Ostericum koreanum, Eucommia ulmoides, Acanthopanax sessiliflorus, Achyranthes bidentata, Psoralea corylifolia, Peucedanum japonicum, Cibotium barometz, Lycium chinense, Boschniakia rossica, Cuscuta chinensis, and Atractylodes japonica).

  • AcupunctureProcedure

    Acupuncture treatment was administered 1-2 times daily using mainly Ah-shi points and local acupuncture points.

  • PharmacopunctureProcedure

    Select ingredients similar to those included in the oral herbal medicine (Ostericum koreanum, Eucommia ulmoides, Acanthopanax Sessiliflorus, Achyranthes bidentata, Psoralea corylifolia, Peucedanum japonicum, Cibotium barometz, Lycium chinense, Boschniakia rossica, Cuscuta chinensis, and Atractylodes japonica) were freeze dried into powder form after decoction, then diluted in normal saline and adjusted for acidity and pH to be used in injections. The pharmacopuncture injections were injected once daily to the amount of 1 cc and Ah-shi points and local acupuncture points (CPL, 1 cc, 26G x 1.5 syringe, Shinchang medical co., Korea).

  • Bee venom pharmacopunctureProcedure

    Bee venom pharmacopuncture was applied after confirming a negative reaction to the hypersensitivity skin test. Diluted bee venom (saline:bee venom ratio, 10,000:1) was injected at 4-5 acupoints at the physician's discretion. Each acupuncture point was injected with approximately 0.2 cc to a total of 0.5-1 cc using disposable injection needles (CPL, 1 cc, 26G x 1.5 syringe, Shinchang medical co., Korea).

  • Chuna manipulationProcedure

    Chuna was administered 3-5 times a week. Chuna is a Korean version of spinal manipulation that incorporates conventional spinal manipulation techniques for mobilization involving high-velocity, low amplitude thrusts to joints slightly beyond the passive range of motion and gentle force to joints within the passive range of movement.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Alanine aminotransferase (ALT)Time frame: Change from baseline (admission) in liver function test up to discharge (average 4 wks)
  2. Aspartate aminotransferase (AST)Time frame: Change from baseline (admission) in liver function test up to discharge (average 4 wks)
  3. Alkaline phosphatase (ALP)Time frame: Change from baseline (admission) in liver function test up to discharge (average 4 wks)
  4. Total bilirubin (TB)Time frame: Change from baseline (admission) in liver function test up to discharge (average 4 wks)

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Jaseng Hospital of Korean Medicine

    Seoul, Gangnam-Gu, South Korea

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.